Intra-amniotic inflammation in human gastroschisis: Possible aetiology of postnatal bowel dysfunction

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 105, Issue 11, 1998, Pages 1200-1204

  Morrison, John J ^a   Klein, Nigel ^b   Chitty, Lyn S ^a   Kocjan, Gabriella ^a   Walshe, Denise ^b   Goulding, Mark ^b   Geary, Michael P ^a   Pierro, Agostino ^b   Rodeck, Charles H ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD11B ANTIGEN; CD15 ANTIGEN; CD18 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AMNION FLUID; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CYTODIAGNOSIS; ENTEROPATHY; FEMALE; FETUS; FETUS DISEASE; FLOW CYTOMETRY; GASTROSCHISIS; HUMAN; MONONUCLEAR CELL; NEUTROPHIL; PRIORITY JOURNAL; THIRD TRIMESTER PREGNANCY; UNITED KINGDOM;

ADULT; AMNIOTIC FLUID; ANTIGENS, CD; DIGESTIVE SYSTEM DISEASES; FEMALE; GASTROSCHISIS; HUMANS; INTERLEUKIN-8; PREGNANCY; PREGNANCY TRIMESTER, THIRD; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031762143     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1998.tb09975.x     Document Type: Article

References (20)

1. Tan KH, Kilby MD, Whittle MJ, Beattie BR, Booth IW, Botting BJ. Congenital anterior abdominal wall defects in England and Wales 1987-1993: retrospective analysis of OPCS data. BMJ 1996; 313: 903–906.
2. Goldbaum G. Daling J, Milham SSO. Risk factors for gastroschisis. Teratology 1990; 42: 397–403.
3. Martinez-Frias MLSO. Gastroschisis: is the prevalencc increaseing AM J MedGenet 1994; 49: 128–130.
4. Werler MM, Mitchell AA, Shapiro SS. Demographic. reproductive, medical and environmental factors in relation to gastroschisis. Teratology 1992; 45: 353–360.
5. Werler MM. Mitchcll AA, Shapiro SS. First trimester maternal medication use in relation to gastroschisis. Teratology 1992; 45: 361–367.
6. Crawford RA, Ryan G, Wright VM, Rodeck CH. The importance of serial biophysical assessment of fetal wellbeing in gastroschisis. Br J Obstet Gynaecol 1992; 99 899–902.
7. Haddock G, Davis CF, Raine PA. Gastroschisis in the decade of prenatal diagnosis: 1983–1993. Eur J Pediatr Surg 1996; 6: 18–22.
8. Stoodley N, Sharma A, James D. Influence of place of delivery on outcome in babies with gastroschisis. Arch Dis Child 1993; 68: 321–323.
9. Iskaros J, Morrison JJ, Chitty LS, Rodeck CH. Epidemiological and sonographic features of fetal gastroschisis and neonatal out come. Br J Obstet Gynaecol 1996; 103: 848.
10. Novotny DA, Klein RL, Boeckman CR. Gastroschisis: an 18-year review. J Pediatr Surg 1993; 28: 650–652.
11. Langer JC, Bell JG, Castillo RO et al. Etiology of intestinal damage in gastroschisis, 11. Timing and reversibility of histological changes, mucosal function and contractility. J Pediatr Surg 1990; 25: 1122–1126.
12. O’Neill JA, Grosfield JL. Intestinal malfunction after antenatal exposure of viscera. Am J Surg 1974; 127: 129–132.
13. Oh KS, Dorst JP, Dominguez R et al. Abnormal intestinal motility in gastroschisis. Radiology 1978; 127: 457–460.
14. Foulon W, Van-Liedekerke D, Demanet C, Decatte L, Dewaele M, Naessens A. Markers of infection and their relationship to preterm delivery. Am J Perinatol 1995; 12: 208–211.
15. Luton D, De Lagauise P, Guibourdenche J et al. Prognostic factors of prenatally diagnosed gastroschisis. Fetal Diagn Ther 1997; 12: 7–14.
16. Halgunset J, Johnsen H, Kjollesdal AM, Qvigstad E, Espevik T, Austgulen R. Cytokine levels in amniotic fluid and inflammatory changes in the placenta from normal deliveries at term. Eur J Obstet Gynecol Reprod Biol 1994; 56: 153–160.
17. Laham N, Brennecke SP, Bendtzen K, Rice GE. Tumour necrosis Factor alpha during pregnancy and labour: maternal plasma and amniotic fluid concentrations and release from intrauterine tissues. Eur J Endocrinol 1994; 131: 607–614.
18. Adams DH, Lloyd AR. Chemokines leucocyte recruitment and activation cytokines. Lancer 1997; 349 490–495.
19. Puchner T, Egarter C, Wimmer C, Lederhilger F, Weichselbraun I. Amniotic fluid interleukin-8 as a marker For intraamniotic infection. Infect Immun 1995; 63: 1681–1687.
20. Guo W, Swaniker F, Fonkalsrud EW, Vo K, Karanianoukian R. Effect of intraamniotic dexamethasone administration on intestinal absorption in a rabbit gdstroschisis model. J Pediutr Surg 1995; 30: 983–986.